NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial.
Lancet (London, England) · 2023 · 424 citations · Sreenivasa Chandana
Pancreatic Cancer: A Review of Current Treatment and Novel Therapies.
Journal of investigative surgery : the official journal of the Academy of Surgical Research · 2023 · 319 citations · Sreenivasa Chandana
Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets.
Nature communications · 2022 · 209 citations · Sujana Movva
Closed-loop stimulation in periods with less epileptiform activity drives improved epilepsy outcomes.
Brain : a journal of neurology · 2024 · 63 citations · Amir Arain
Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium.
Annals of oncology : official journal of the European Society for Medical Oncology · 2021 · 260 citations · Rohit Bishnoi
The effectiveness of incentives for research participation: A systematic review and meta-analysis of randomized controlled trials.
PloS one · 2022 · 95 citations ·
Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025 · 36 citations · Sreenivasa Chandana
Loss of synovial tissue macrophage homeostasis precedes rheumatoid arthritis clinical onset.
Science advances · 2024 · 64 citations · Sunil Nagpal